First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia - Concepedia

Concepedia

Publication | Open Access

First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe and Critical COVID-19 Pneumonia

DOI Full Paper Access

26

Citations

18

References

2020

Year

Zelalem Temesgen, Mariam Assi, Paschalis Vergidis, Stacey A. Rizza, Philippe R. Bauer, Brian W. Pickering, Raymund R. Razonable, Claudia R. Libertin, Charles D. Burger, Robert Orenstein,

Unknown Venue

Abstract

In high-risk COVID-19 patients with severe pneumonia, GM-CSF neutralization with lenzilumab was safe and associated with improved clinical outcomes, oxygen requirement, and cytokine storm.

References

	Year	Citations

Page 1